IDE and Alzheimer disease: For instance, insulin-degrading enzyme (IDE) which degrades Aβ, is claimed to be dysfunctional in AD and contributes to its pathogenesis [51, 52], while IDE activity is inhibited by glucocorticoids neprilysin, which rduces Aβ load, [53, 54].